Emflaza Prices, Coupons, Copay Cards & Patient Assistance
Emflaza (deflazacort) is a member of the glucocorticoids drug class and is commonly used for Duchenne Muscular Dystrophy.
The cost for Emflaza (22.75 mg/mL) oral suspension is around $7,206 for a supply of 13 milliliters, depending on the pharmacy you visit. Quoted prices are for cash-paying customers and are not valid with insurance plans. This price guide is based on using the Drugs.com discount card which is accepted at most U.S. pharmacies.
A generic version of Emflaza has been approved by the FDA. However, we either do not have pricing information for it, or it is not commercially available. View generic Emflaza availability for more details.
Emflaza prices
Oral Suspension
22.75 mg/mL
Emflaza oral suspension
from $7,205.89
for 13 milliliters
| Quantity | Per unit | Price |
|---|---|---|
| 13 milliliters | $554.30 | $7,205.89 |
Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.
Oral Tablet
6 mg
Emflaza oral tablet
from $10,932.85
for 100 tablets
| Quantity | Per unit | Price |
|---|---|---|
| 100 | $109.33 | $10,932.85 |
Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.
18 mg
Emflaza oral tablet
from $9,840.80
for 30 tablets
| Quantity | Per unit | Price |
|---|---|---|
| 30 | $328.03 | $9,840.80 |
Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.
30 mg
Emflaza oral tablet
from $16,395.52
for 30 tablets
| Quantity | Per unit | Price |
|---|---|---|
| 30 | $546.52 | $16,395.52 |
Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.
36 mg
Emflaza oral tablet
from $18,978.08
for 30 tablets
| Quantity | Per unit | Price |
|---|---|---|
| 30 | $632.60 | $18,978.08 |
Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.
Drugs.com Printable Discount Card
The free Drugs.com Discount Card works like a coupon and can save you up to 80% or more off the cost of prescription medicines, over-the-counter drugs and pet prescriptions.
Print Free Discount CardNote: This is a drug discount program, not an insurance plan. Valid at all major chains including Walgreens, Target, WalMart Pharmacy, Duane Reade and 65,000 pharmacies nationwide.
Emflaza Coupons, Copay Cards and Rebates
Emflaza offers may take the form of printable coupons, rebates, savings or copay cards, trial offers, or free samples. Certain offers may be printable from a website while others may require registration, completing a questionnaire, or obtaining a sample from a medical professional.
Emflaza Copay Assistance Program
Eligible commercially insured patients may qualify for copay assistance with out-of-pocket costs.
- Applies to:
- Emflaza
- Number of uses:
- Contact the program
Form more information phone: 844-478-2227 or Visit website
Emflaza Bridge Program
Eligible patients may receive a temporary supply of medication FREE of charge while waiting for insurance coverage decision or verification.
- Applies to:
- Emflaza
- Number of uses:
- Temporary Assistance
Form more information phone: 844-478-2227 or Visit website
Patient Assistance & Copay Programs for Emflaza
Patient assistance programs (PAPs) are typically sponsored by pharmaceutical companies and offer cost-free or discounted medicines, as well as copay programs, to individuals with low income or those who are uninsured/under-insured and meet specific criteria. Eligibility requirements for each program may vary.
Provider: Patient Access Network Foundation (PAN)
Eligibility requirements:- *See Additional Information section below
- Between 400-500% of FPL
- FDA Approved Diagnosis - See Program Website for Details
- Must reside and receive treatment in US
- *Patients must have health insurance and their insurance must cover the qualifying medication for which they seek assistance. Call for most recent medications as the list is subject to change and the medication for which you are seeking assistance must treat the disease directly. Note: All new enrollment is now done electronically or over the phone. Contact program for details.
- Emflaza (deflazacort)
More information please phone: 866-316-7263 Visit Website
Provider: PTC Cares Program
Eligibility requirements:- Contact program for details.
- Not disclosed
- Medically Necessary as determined by a Doctor
- Must be residing in the US or US territory
- Co-payment assistance, patient support, and patient assistance programs are available for eligible patients. This program may provide a Bridge Program for eligible patients. Contact program for details.
- Emflaza (deflazacort)
More information please phone: 844-478-2227 Visit Website
Disclaimer: Medication pricing is sourced from a variety of providers. Pricing may vary significantly due to several factors including brand or generic status, insurance coverage, pharmacy choice, location, and manufacturer pricing policies. Prices are subject to change. For the most accurate and up-to-date information, always consult directly with your pharmacy or healthcare provider.
See also:
Amondys 45
Amondys 45 (casimersen) is used to treat Duchenne muscular dystrophy (DMD) with a genetic mutation ...
Agamree
Agamree (vamorolone) is an FDA-approved treatment for Duchenne muscular dystrophy (DMD) to improve ...
Elevidys
Elevidys is a gene therapy for Duchenne muscular dystrophy, that is given as a one-time infusion ...
Duvyzat
Duvyzat (givinostat) is used to treat Duchenne muscular dystrophy (DMD) to delay symptoms and ...
Vyondys 53
Vyondys 53 is used for Duchenne muscular dystrophy (DMD) in children and young adults with a ...
Exondys 51
Exondys 51 is used for Duchenne Muscular Dystrophy (DMD) in children and young adults with a ...
Viltepso
Viltepso (viltolarsen) is used for the treatment of Duchenne muscular dystrophy (DMD) treatable ...
Vamorolone
Vamorolone (Agamree) is a novel corticosteroid used to treat Duchenne muscular dystrophy (DMD) ...
Givinostat
Givinostat (Duvyzat) is used to treat Duchenne muscular dystrophy (DMD) to delay symptoms and ...
Eteplirsen
Eteplirsen is used for Duchenne Muscular Dystrophy (DMD) in children and young adults with a gene ...
More about Emflaza (deflazacort)
- Check interactions
- Compare alternatives
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Generic availability
- FDA approval history
- Drug class: glucocorticoids
- Breastfeeding
- En español
